371 related articles for article (PubMed ID: 33751753)
1. CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?
Rodríguez-Goncer I; Ruiz-Ruigómez M; López-Medrano F; Corbella L; Polanco N; González Monte E; San Juan R; Ruiz-Merlo T; Parra P; Folgueira L; Andrés A; Aguado JM; Fernández-Ruiz M
Transpl Infect Dis; 2021 Aug; 23(4):e13597. PubMed ID: 33751753
[TBL] [Abstract][Full Text] [Related]
2. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.
Reischig T; Kacer M; Hes O; Machova J; Nemcova J; Lysak D; Jindra P; Pivovarcikova K; Kormunda S; Bouda M
Am J Transplant; 2019 Sep; 19(9):2457-2467. PubMed ID: 31220412
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
[TBL] [Abstract][Full Text] [Related]
5. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
[TBL] [Abstract][Full Text] [Related]
6. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
7. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
8. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
10. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
[TBL] [Abstract][Full Text] [Related]
11. IVIg therapy in the management of BK virus infections in pediatric kidney transplant patients.
Mosca M; Bacchetta J; Chamouard V; Rascle P; Dubois V; Paul S; Mekki Y; Picard C; Bertholet-Thomas A; Ranchin B; Sellier-Leclerc AL
Arch Pediatr; 2023 Apr; 30(3):165-171. PubMed ID: 36907728
[TBL] [Abstract][Full Text] [Related]
12. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
13. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
15. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
[TBL] [Abstract][Full Text] [Related]
16. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
[TBL] [Abstract][Full Text] [Related]
17. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
[TBL] [Abstract][Full Text] [Related]
18. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation.
Jehn U; Schütte-Nütgen K; Bautz J; Pavenstädt H; Suwelack B; Thölking G; Reuter S
Sci Rep; 2020 Dec; 10(1):22406. PubMed ID: 33376243
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.
Demey B; Tinez C; François C; Helle F; Choukroun G; Duverlie G; Castelain S; Brochot E
J Clin Virol; 2018 Dec; 109():6-12. PubMed ID: 30343190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
